The Standing Committee of the National People's Congress announced on April 26 that the Standing Committee of the Tibet Autonomous Region People's Congress decided to dismiss Yang Xiaoming's 14th National People's Congress.According to the relevant provisions of the National People's Congress of the People's Republic of China and the representative law of the People's Congress at all levels, Yang Xiaoming's representative qualification was terminated.
In addition, in accordance with the relevant provisions of the National People's Congress of the People's Republic of China and the election law of the People's Congress at all levels, Yang Xiaoming ’s members of the Fourteenth National People's Congress of the National People's Congress were revoked accordingly.
According to the Earlier Report of the Standing Committee of the National People's Congress, the Earlier report of the Standing Committee of the National People's Congress reported that the 14th National People's Congress of Tibet Autonomous Region selected by the Tibet Autonomous Region, member of the 14th National People's Congress, member of the National People's Congress, China Pharmaceutical Group Co., Ltd.Yang Xiaoming, the former chief engineer and chief scientist, was suspected of serious disciplinary violations. On March 29, 2024, the Ninth Meeting of the Standing Committee of the Twelfth People's Congress of the Tibet Autonomous Region decided to dismiss Yang Xiaoming's 14th National People's Congress.
Public information shows that Yang Xiaoming, born in February 1962, is an expert in biological products. He was the director of the National Joint Vaccine Engineering Technology Research Center, the chief scientist of the National "863" plan vaccine project, and the chairman of China Biological Biology.
